NeoImmuneTech, Inc. (KOSDAQ: 950220)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,260.00
+20.00 (1.61%)
Nov 15, 2024, 9:00 AM KST
-13.64%
Market Cap 24.32B
Revenue (ttm) n/a
Net Income (ttm) -46.56B
Shares Out 19.77M
EPS (ttm) -470.97
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 325,439
Open 1,194.00
Previous Close 1,240.00
Day's Range 1,194.00 - 1,265.00
52-Week Range 1,180.00 - 2,130.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About NeoImmuneTech

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 82
Stock Exchange KOSDAQ
Ticker Symbol 950220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.